LogicBio Therapeutics, Inc. (LOGC): Price and Financial Metrics
LOGC Price/Volume Stats
| Current price | $6.94 | 52-week high | $9.34 |
| Prev. close | $6.68 | 52-week low | $4.92 |
| Day low | $6.54 | Volume | 2,666,900 |
| Day high | $6.97 | Avg. volume | 405,690 |
| 50-day MA | $7.19 | Dividend yield | N/A |
| 200-day MA | $6.82 | Market Cap | 184.69M |
LOGC Stock Price Chart Interactive Chart >
LogicBio Therapeutics, Inc. (LOGC) Company Bio
LogicBio Therapeutics, Inc. is a genome editing company, which engages in developing medicines to treat rare diseases in patients with significant unmet medical need. It focuses on the commercialization of specific genome editing and integration of the therapeutic transgene. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Cambridge, MA.
LOGC Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
LOGC Price Returns
| 1-mo | -3.61% |
| 3-mo | -4.28% |
| 6-mo | -13.68% |
| 1-year | 25.27% |
| 3-year | -88.43% |
| 5-year | N/A |
| YTD | -1.28% |
| 2024 | 18.15% |
| 2023 | -59.33% |
| 2022 | -84.32% |
| 2021 | -82.95% |
| 2020 | N/A |